PharmaTher Holdings Announces U.S. Patent Grant for Ketamine
The issuance of the US patent strengthens PharmaTher’s intellectual property portfolio covering novel uses and dosage forms of ketamine Announcement of positive efficacy and safety
The issuance of the US patent strengthens PharmaTher’s intellectual property portfolio covering novel uses and dosage forms of ketamine Announcement of positive efficacy and safety
NEWTON, MA and GENEVA, October 3, 2022 (GLOBE NEWSWIRE) — Acer Therapeutics Inc. ACER (Acer) and RELIEF THERAPEUTICS Holding SA (RLFRLFTF RLFTY)) (Relief) announced today
NEW YORK, Sept. 27, 2022 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of Medtronic Plc (“Medtronic” or the “Company”) MDT.
NEW YORK, Sept. 27, 2022 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors in Medtronic Plc (“Medtronic” or the “Company”) (NYSE:
NEW YORK, Sept. 26, 2022 (GLOBE NEWSWIRE) — Bragar Eagel & Squire, PC, a nationally recognized shareholder rights law firm, is reminding investors that class
NEW YORK, Sept. 26, 2022 (GLOBE NEWSWIRE) — Bragar Eagel & Squire, PC, a nationally recognized shareholder rights law firm, is reminding investors that class
LOS ANGELES, Sept. 23, 2022 (GLOBE NEWSWIRE) — Glancy Prongay & Murray LLP (“GPM”) reminds investors of what’s to come October 17, 2022 Deadline for
LOS ANGELES, Sept. 23, 2022 (GLOBE NEWSWIRE) — Glancy Prongay & Murray LLP (“GPM”) reminds investors of what’s to come October 17, 2022 Deadline for
NEW YORK, Sept. 21, 2022 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of Medtronic Plc (“Medtronic” or the “Company”) MDT.
NEW YORK, Sept. 21, 2022 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors in Medtronic Plc (“Medtronic” or the “Company”) (NYSE:
LOS ANGELES, Sept. 19, 2022 (GLOBE NEWSWIRE) — Glancy Prongay & Murray LLP (“GPM”) reminds investors of what’s to come October 17, 2022 Deadline for
LOS ANGELES, Sept. 19, 2022 (GLOBE NEWSWIRE) — Glancy Prongay & Murray LLP (“GPM”) reminds investors of what’s to come October 17, 2022 Deadline for
The issuance of the US patent strengthens PharmaTher’s intellectual property portfolio covering novel uses and dosage forms of ketamine Announcement of positive efficacy and safety
NEWTON, MA and GENEVA, October 3, 2022 (GLOBE NEWSWIRE) — Acer Therapeutics Inc. ACER (Acer) and RELIEF THERAPEUTICS Holding SA (RLFRLFTF RLFTY)) (Relief) announced today
NEW YORK, Sept. 27, 2022 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of Medtronic Plc (“Medtronic” or the “Company”) MDT.
NEW YORK, Sept. 27, 2022 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors in Medtronic Plc (“Medtronic” or the “Company”) (NYSE:
NEW YORK, Sept. 26, 2022 (GLOBE NEWSWIRE) — Bragar Eagel & Squire, PC, a nationally recognized shareholder rights law firm, is reminding investors that class
NEW YORK, Sept. 26, 2022 (GLOBE NEWSWIRE) — Bragar Eagel & Squire, PC, a nationally recognized shareholder rights law firm, is reminding investors that class
LOS ANGELES, Sept. 23, 2022 (GLOBE NEWSWIRE) — Glancy Prongay & Murray LLP (“GPM”) reminds investors of what’s to come October 17, 2022 Deadline for
LOS ANGELES, Sept. 23, 2022 (GLOBE NEWSWIRE) — Glancy Prongay & Murray LLP (“GPM”) reminds investors of what’s to come October 17, 2022 Deadline for
NEW YORK, Sept. 21, 2022 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of Medtronic Plc (“Medtronic” or the “Company”) MDT.
NEW YORK, Sept. 21, 2022 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors in Medtronic Plc (“Medtronic” or the “Company”) (NYSE:
LOS ANGELES, Sept. 19, 2022 (GLOBE NEWSWIRE) — Glancy Prongay & Murray LLP (“GPM”) reminds investors of what’s to come October 17, 2022 Deadline for
LOS ANGELES, Sept. 19, 2022 (GLOBE NEWSWIRE) — Glancy Prongay & Murray LLP (“GPM”) reminds investors of what’s to come October 17, 2022 Deadline for